Cure My Disease

Don't miss your cure!

 Log in / Sign up

Implantable pump for PAH drug passes safety check

NCT ID NCT01321073

Ongoing Disease control Sponsor: Medtronic Cardiac Rhythm and Heart Failure Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests an implanted catheter and pump system that delivers Remodulin, a drug for pulmonary arterial hypertension (PAH), directly into the bloodstream. The goal is to see if this device is safe for long-term use. The trial includes 64 patients who already use the system. The study is no longer seeking approval but continues to support those still implanted.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Remodulin (treprostinil) injection
What this could lead to
If successful, this could confirm a safer way to deliver PAH medication through an implanted pump, reducing infection risks.
What could go wrong
The trial is small (64 participants) and no longer pursuing approval. It only supports existing patients, so results may not lead to a new treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PULMONARY ARTERIAL HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pulmonary arterial hypertension

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PULMONARY ARTERIAL HYPERTENSION

Contacts and locations

Locations

  • AdventHealth Orlando

    Orlando, Florida, 32803, United States

  • Aurora St. Lukes Medical Center

    Milwaukee, Wisconsin, 53234, United States

  • Brigham & Women's Hospital

    Boston, Massachusetts, 02115, United States

  • Mayo Clinic

    Rochester, Minnesota, 55905, United States

  • University of Alabama at Birmingham

    Birmingham, Alabama, 35294, United States

  • University of Chicago Medical Center

    Chicago, Illinois, 60637, United States

  • University of Texas Southwestern Medical Center

    Dallas, Texas, 75390-7208, United States

  • VA Greater Los Angeles Healthcare System

    Los Angeles, California, 90073, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.